Avid Bioservices Inc logo

Avid Bioservices Inc share price today

(CDMO)

Avid Bioservices Inc share price is $12.28 & ₹1,039.42 as on 7 Dec 2024, 2.30 'hrs' IST

$12.28

-0.01

(-0.08%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Avid Bioservices Inc share price in Dollar and Rupees. Guide to invest in Avid Bioservices Inc from India. Also see the sentimental analysis on Indian investors investing in Avid Bioservices Inc. Get details on the Indian mutual funds that are investing in Avid Bioservices Inc. Get Analyst recommendations and forecasts along with all the Avid Bioservices Inc's financials.

Avid Bioservices Inc share price movements

  • $12.25
    $12.31

    Day's Volatility :0.45%

  • $4.07
    $12.48

    52 Weeks Volatility :67.38%

Avid Bioservices Inc Returns

PeriodAvid Bioservices IncSector (Health Care)Index (Russel 2000)
3 Months
37.32%
-5.7%
0.0%
6 Months
52.48%
-0.8%
0.0%
1 Year
164.87%
9.9%
0.0%
3 Years
-56.29%
10.7%
-19.7%

Avid Bioservices Inc Key Statistics

in dollars & INR

Previous Close
$12.29
Open
$12.32
Today's High
$12.305
Today's Low
$12.25
Market Capitalization
$789.9M
Today's Volume
$712.1K
52 Week High
$12.48
52 Week Low
$4.0705
Revenue TTM
$142.4M
EBITDA
$-7.7M
Earnings Per Share (EPS)
$-2.29
Profit Margin
-101.27%
Quarterly Earnings Growth YOY
-0.8%
Return On Equity TTM
-115.84%

How to invest in Avid Bioservices Inc from India?

It is very easy for Indian residents to invest directly in Avid Bioservices Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avid Bioservices Inc stock in both rupees (INR) and dollars (USD). Search for Avid Bioservices Inc or CDMO on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avid Bioservices Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avid Bioservices Inc shares which would translate to 0.069 fractional shares of Avid Bioservices Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Avid Bioservices Inc

214%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Avid Bioservices Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 214% more investors are searching Avid Bioservices Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Avid Bioservices Inc

  • BlackRock Inc

    7.98%

  • Millennium Management LLC

    6.55%

  • Vanguard Group Inc

    6.01%

  • Point72 Asset Management, L.P.

    5.97%

  • AltraVue Capital, LLC

    5.94%

  • State Street Corp

    4.69%

Analyst Recommendation on Avid Bioservices Inc

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Avid Bioservices Inc(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Avid Bioservices Inc

What analysts predicted

Upside of 3.83%

Current:

$12.28

Target:

$12.75

Insights on Avid Bioservices Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 42.97M → 40.17M (in $), with an average decrease of 6.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -123.10M → -5.53M (in $), with an average increase of 2124.5% per quarter
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 98.7%

Avid Bioservices Inc Financials in INR & Dollars

FY19Y/Y Change
Revenue
$53.6M
↓ 0.03%
Net Income
$-4.2M
↓ 80.68%
Net Profit Margin
-7.86%
↑ 32.82%
FY20Y/Y Change
Revenue
$59.7M
↑ 11.38%
Net Income
$-7.3M
↑ 72.15%
Net Profit Margin
-12.15%
↓ 4.29%
FY21Y/Y Change
Revenue
$95.9M
↑ 60.58%
Net Income
$11.2M
↓ 254.52%
Net Profit Margin
11.7%
↑ 23.85%
FY22Y/Y Change
Revenue
$119.6M
↑ 24.75%
Net Income
$127.7M
↑ 1038.71%
Net Profit Margin
106.75%
↑ 95.05%
FY23Y/Y Change
Revenue
$149.3M
↑ 24.81%
Net Income
$560.0K
↓ 99.56%
Net Profit Margin
0.38%
↓ 106.37%
FY24Y/Y Change
Revenue
$139.9M
↓ 6.27%
Net Income
$-140.8M
↓ 25234.46%
Net Profit Margin
-100.6%
↓ 100.98%
Q2 FY23Q/Q Change
Revenue
$39.8M
↑ 4.68%
Net Income
$-309.0K
↓ 167.03%
Net Profit Margin
-0.78%
↓ 1.99%
Q3 FY23Q/Q Change
Revenue
$37.7M
↓ 5.21%
Net Income
$-2.1M
↑ 577.35%
Net Profit Margin
-5.55%
↓ 4.77%
Q4 FY23Q/Q Change
Revenue
$25.4M
↓ 32.69%
Net Income
$-9.5M
↑ 354.32%
Net Profit Margin
-37.44%
↓ 31.89%
Q1 FY24Q/Q Change
Revenue
$33.8M
↑ 33.16%
Net Income
$-6.0M
↓ 36.84%
Net Profit Margin
-17.76%
↑ 19.68%
Q2 FY24Q/Q Change
Revenue
$43.0M
↑ 27.09%
Net Income
$-123.1M
↑ 1949.68%
Net Profit Margin
-286.45%
↓ 268.69%
Q3 FY24Q/Q Change
Revenue
$40.2M
↓ 6.52%
Net Income
$-5.5M
↓ 95.5%
Net Profit Margin
-13.78%
↑ 272.67%
FY19Y/Y Change
Total Assets
$78.4M
↓ 18.13%
Total Liabilities
$25.3M
↓ 36.72%
FY20Y/Y Change
Total Assets
$107.6M
↑ 37.28%
Total Liabilities
$65.7M
↑ 159.5%
FY21Y/Y Change
Total Assets
$265.5M
↑ 146.71%
Total Liabilities
$187.8M
↑ 185.7%
FY22Y/Y Change
Total Assets
$429.8M
↑ 61.89%
Total Liabilities
$255.3M
↑ 35.97%
FY23Y/Y Change
Total Assets
$451.1M
↑ 4.93%
Total Liabilities
$261.6M
↑ 2.45%
FY24Y/Y Change
Total Assets
$336.6M
↓ 25.38%
Total Liabilities
$275.7M
↑ 5.38%
Q2 FY23Q/Q Change
Total Assets
$451.1M
↑ 0.14%
Total Liabilities
$261.6M
↓ 1.3%
Q3 FY23Q/Q Change
Total Assets
$442.3M
↓ 1.93%
Total Liabilities
$251.7M
↓ 3.76%
Q4 FY23Q/Q Change
Total Assets
$454.6M
↑ 2.78%
Total Liabilities
$271.0M
↑ 7.64%
Q1 FY24Q/Q Change
Total Assets
$455.2M
↑ 0.13%
Total Liabilities
$275.1M
↑ 1.51%
Q2 FY24Q/Q Change
Total Assets
$336.6M
↓ 26.07%
Total Liabilities
$275.7M
↑ 0.22%
Q3 FY24Q/Q Change
Total Assets
$334.6M
↓ 0.57%
Total Liabilities
$276.0M
↑ 0.12%
FY19Y/Y Change
Operating Cash Flow
$-11.6M
↓ 56.68%
Investing Cash Flow
$4.5M
↓ 24015.79%
Financing Cash Flow
$-2.9M
↓ 112.87%
FY20Y/Y Change
Operating Cash Flow
$5.8M
↓ 150.25%
Investing Cash Flow
$-3.8M
↓ 183.89%
Financing Cash Flow
$1.1M
↓ 138.28%
FY21Y/Y Change
Operating Cash Flow
$31.2M
↑ 435.13%
Investing Cash Flow
$-9.9M
↑ 158.76%
Financing Cash Flow
$112.3M
↑ 10149.54%
FY22Y/Y Change
Operating Cash Flow
$9.5M
↓ 69.65%
Investing Cash Flow
$-56.4M
↑ 471.89%
Financing Cash Flow
$3.2M
↓ 97.15%
FY23Y/Y Change
Operating Cash Flow
$-12.9M
↓ 236.15%
Investing Cash Flow
$-77.6M
↑ 37.63%
Financing Cash Flow
$2.9M
↓ 9.26%
Q2 FY23Q/Q Change
Operating Cash Flow
$2.8M
↓ 140.48%
Investing Cash Flow
$-24.9M
↑ 119.59%
Financing Cash Flow
$704.0K
↓ 18.89%
Q3 FY23Q/Q Change
Operating Cash Flow
$-278.0K
↓ 109.93%
Investing Cash Flow
$-14.1M
↓ 43.26%
Financing Cash Flow
$748.0K
↑ 6.25%

Avid Bioservices Inc Technicals Summary

Sell

Neutral

Buy

Avid Bioservices Inc is currently in a neutral trading position according to technical analysis indicators.

Avid Bioservices Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avid Bioservices Inc
0.41%
52.48%
164.87%
-56.29%
110.09%
Regeneron Pharmaceuticals, Inc.
-5.97%
-23.34%
-8.6%
17.41%
110.02%
Biontech Se
11.44%
21.29%
14.9%
-59.29%
309.79%
Alnylam Pharmaceuticals, Inc.
-7.77%
64.08%
48.09%
42.33%
108.61%
Vertex Pharmaceuticals Incorporated
-6.83%
-4.83%
31.35%
122.6%
109.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avid Bioservices Inc
1250.0
NA
NA
-0.32
-1.16
-0.03
NA
0.92
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avid Bioservices Inc
Buy
$789.9M
110.09%
1250.0
-101.27%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
110.02%
18.56
33.61%
Biontech Se
Buy
$28.5B
309.79%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
108.61%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.65%
32.84
-4.51%

About Avid Bioservices Inc

avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.
Organization
Avid Bioservices Inc
Employees
371
CEO
Mr. Nicholas Stewart Green B.Sc., MBA
Industry
Health Technology

Management People of Avid Bioservices Inc

NameTitle
Mr. Nicholas Stewart Green B.Sc., MBA
President, CEO & Director
Mr. Daniel R. Hart
Chief Financial Officer
Mr. Richard A. Richieri
Chief Operations Officer
Mr. Mark R. Ziebell J.D.
VP, General Counsel & Corporate Secretary
Mr. Matthew R. Kwietniak
Chief Commercial Officer

Important FAQs about investing in Avid Bioservices Inc from India :

What is Avid Bioservices Inc share price today?

Avid Bioservices Inc (CDMO) share price today is $12.28.

Can Indians buy Avid Bioservices Inc shares?

Yes, Indians can invest in the Avid Bioservices Inc (CDMO) from India.

With INDmoney, you can buy Avid Bioservices Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avid Bioservices Inc at zero transaction cost.

How can I buy Avid Bioservices Inc shares from India?

It is very easy to buy Avid Bioservices Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avid Bioservices Inc be purchased?

Yes, you can buy fractional shares of Avid Bioservices Inc with INDmoney app.

What are the documents required to start investing in Avid Bioservices Inc stocks?

To start investing in Avid Bioservices Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Avid Bioservices Inc

Today’s highest price of Avid Bioservices Inc (CDMO) is $12.31.

Today’s lowest price of Avid Bioservices Inc (CDMO) is $12.25.

What is today's market capitalisation of Avid Bioservices Inc

Today's market capitalisation of Avid Bioservices Inc CDMO is 789.9M

What is the 52 Week High and Low Range of Avid Bioservices Inc

  • 52 Week High

    $12.48

  • 52 Week Low

    $4.07

How much percentage Avid Bioservices Inc is down from its 52 Week High?

Avid Bioservices Inc (CDMO) share price is $12.28. It is down by 99% from its 52 Week High price of $12.48.

How much percentage Avid Bioservices Inc is up from its 52 Week low?

Avid Bioservices Inc (CDMO) share price is $12.28. It is up by 1% from its 52 Week Low price of $4.07.

What are the historical returns of Avid Bioservices Inc?

  • 1 Month Returns

    0.41%

  • 3 Months Returns

    52.48%

  • 1 Year Returns

    164.87%

  • 5 Years Returns

    110.09%

Who is the Chief Executive Officer (CEO) of Avid Bioservices Inc

Mr. Nicholas Stewart Green B.Sc., MBA is the current Chief Executive Officer (CEO) of Avid Bioservices Inc.